Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Pincus

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Clinical and Experimental Immunology|September 23, 2008
Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cellsS L Fu, J Pierre, T A Smith-Norowitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
erbB-2 and myc oncoproteins in sera and tumors of breast cancer patientsB Breuer, I De Vivo, J C Luo, et al.
Experimental Cell Research|August 30, 2001
Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytesM Ranginwale, S Smith, J Flom, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturationC Kovac, L Clie, J Morin, et al.
Annals of Clinical and Laboratory Science|March 18, 2000
Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinaseA Villafania, K Anwar, S Amar, et al.
The EMBO Journal|March 4, 1999
Regulation of JNK signaling by GSTpV Adler, Z Yin, S Y Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Conformation-dependent phosphorylation of p53V Adler, M R Pincus, T Minamoto, et al.
Molecular and Cellular Biology|April 3, 2001
Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stressT Buschmann, O Potapova, A Bar-Shira, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2000
Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathwayL Chie, S Amar, H F Kung, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Clinical and Experimental Immunology|September 23, 2008
Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cellsS L Fu, J Pierre, T A Smith-Norowitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
erbB-2 and myc oncoproteins in sera and tumors of breast cancer patientsB Breuer, I De Vivo, J C Luo, et al.
Experimental Cell Research|August 30, 2001
Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytesM Ranginwale, S Smith, J Flom, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturationC Kovac, L Clie, J Morin, et al.
Annals of Clinical and Laboratory Science|March 18, 2000
Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinaseA Villafania, K Anwar, S Amar, et al.
The EMBO Journal|March 4, 1999
Regulation of JNK signaling by GSTpV Adler, Z Yin, S Y Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cellsM Kanovsky, A Raffo, L Drew, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Conformation-dependent phosphorylation of p53V Adler, M R Pincus, T Minamoto, et al.
Molecular and Cellular Biology|April 3, 2001
Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stressT Buschmann, O Potapova, A Bar-Shira, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2000
Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathwayL Chie, S Amar, H F Kung, et al.
Pageof 12